3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Recurrence
3
Neoplasm Metastasis
3
Melanoma
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Cutaneous Squamous Cell Carcinoma
2
Carcinoma, Basal Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Breast Neoplasms
1
Advanced Non-Small Cell Lung Carcinoma
1
Adenocarcinoma
1
Interventions
Gemcitabine
18
Cisplatin
12
Oxaliplatin
7
pembrolizumab
6
Nivolumab
6
Capecitabine
4
trametinib
3
Fluorouracil
3
Bevacizumab
3
tremelimumab
2
lenvatinib
2
durvalumab
2
derazantinib
2
atezolizumab
2
Trastuzumab
2
Ramucirumab
2
Radiofrequency Ablation
2
Panitumumab
2
Leucovorin
2
Cryosurgery
2
zanidatamab
1
vandetanib
1
tucatinib
1
tocilizumab
1
telotristat ethyl
1
sargramostim
1
rucaparib
1
regorafenib
1
pertuzumab
1
milademetan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Biliary Tract Neoplasms
×
cemiplimab
×
Clear all
No trials found.